Detalhe da pesquisa
1.
Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.
Gynecol Oncol
; 181: 125-132, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159362
2.
Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high-grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study.
BJOG
; 129 Suppl 2: 5-13, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36485072
3.
Comparison of two types of the triple incision technique in the treatment of patients with locally advanced vulvar cancer.
Int J Med Sci
; 17(16): 2578-2584, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33029100
4.
Can radical parametrectomy be omitted in occult cervical cancer after extrafascial hysterectomy?
Chin J Cancer
; 34(9): 413-9, 2015 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-26253113
5.
A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer.
J Gynecol Oncol
; 35(1): e1, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37477105
6.
Association between subtypes of metabolic syndrome and prognosis in patients with stage I endometrioid adenocarcinoma: A retrospective cohort study.
Front Oncol
; 12: 950589, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36203442
7.
Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer.
Cancer Manag Res
; 13: 9297-9304, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35221720
8.
A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy.
Front Oncol
; 11: 616264, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33777754
9.
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients.
J Ovarian Res
; 14(1): 9, 2021 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33419462
10.
The added value of CA125 normalization before interval debulking surgery to the chemotherapy response score for the prognostication of ovarian cancer patients receiving neoadjuvant chemotherapy for advanced disease.
J Cancer
; 12(3): 946-953, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403051
11.
Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial.
BMJ Open
; 11(12): e046415, 2021 12 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34916306
12.
Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram.
Front Oncol
; 10: 560888, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33123471
13.
Impact of Poor Preoperative Glycemic Control on Outcomes among Patients with Cervical Cancer Undergoing a Radical Hysterectomy.
Oncol Res Treat
; 43(1-2): 10-18, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31747660
14.
The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
Cancer Med
; 8(11): 5068-5078, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31310455
15.
Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience.
Cancer Manag Res
; 11: 6931-6940, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31440085
16.
Impact of Hyperglycemia on Outcomes among Patients Receiving Neoadjuvant Chemotherapy for Bulky Early Stage Cervical Cancer.
PLoS One
; 11(11): e0166612, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27851819
17.
Pretreatment serum lactate dehydrogenase is an independent prognostic factor for patients receiving neoadjuvant chemotherapy for locally advanced cervical cancer.
Cancer Med
; 5(8): 1863-72, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27350066
18.
Impact of the care provided by gynecologic oncologists on outcomes of cervical cancer patients treated with radical hysterectomy.
Onco Targets Ther
; 9: 1361-70, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27022291